Live · Q4 2026

Tržišta EU,
u jednom kanalu.

Informacijski sloj iza ViraChemove B2B platforme. Aktualne spot cijene, R&D novosti iz otvorenih registara i terenska istraživanja za farmaceutske i biotehnološke laboratorije diljem Europe — izravno iz naše trgovinske mreže, uz osvježavanje svaki sat.

Pregledaj cijene uživo →Otvori feed R&D novosti

Stavke s cijenom

Sirovi prah · cijena kg-razreda

7-dnevni prosjek Δ

+0.8%▲

Kroz aktivne stavke

FX · ECB

EUR/USD

Dnevni referentni tečaj

Učestalost

1 h

TTL na svakom retku

LIVE

BPCIn Vivo€156▼ -5.5%GHKIn Vivo€4▼ -3.5%MOTIn Vivo€277▼ -4.8%CJCIn Vivo€512▼ -1.4%EPIIndustrial€105▲ +9.3%THYIn Vivo€562▼ -5.7%THY3Industrial€165▼ -4.5%AMIIn Vivo€2▼ -2.4%AODIn Vivo€874▼ -5.4%DSIIn Vivo€196▲ +7.9%IPAIn Vivo€243▼ -4.8%KPVIn Vivo€223▼ -1.7%KISIn Vivo€285▼ -5.3%LLAIn Vivo€774▲ +3.7%MELIndustrial€162▲ +5.7%NADIn Vivo€1▲ +8.5%PEGIn Vivo€1,380▲ +11.0%PTAIn Vivo€378▲ +6.3%RETIn Vivo€164▼ -8.2%SS3In Vivo€329▲ +11.0%SELIn Vivo€187▼ -0.9%SEMIn Vivo€192▲ +2.9%TESIn Vivo€541▲ +5.8%THY4In Vivo€571▲ +2.3%BPCIn Vivo€156▼ -5.5%GHKIn Vivo€4▼ -3.5%MOTIn Vivo€277▼ -4.8%CJCIn Vivo€512▼ -1.4%EPIIndustrial€105▲ +9.3%THYIn Vivo€562▼ -5.7%THY3Industrial€165▼ -4.5%AMIIn Vivo€2▼ -2.4%AODIn Vivo€874▼ -5.4%DSIIn Vivo€196▲ +7.9%IPAIn Vivo€243▼ -4.8%KPVIn Vivo€223▼ -1.7%KISIn Vivo€285▼ -5.3%LLAIn Vivo€774▲ +3.7%MELIndustrial€162▲ +5.7%NADIn Vivo€1▲ +8.5%PEGIn Vivo€1,380▲ +11.0%PTAIn Vivo€378▲ +6.3%RETIn Vivo€164▼ -8.2%SS3In Vivo€329▲ +11.0%SELIn Vivo€187▼ -0.9%SEMIn Vivo€192▲ +2.9%TESIn Vivo€541▲ +5.8%THY4In Vivo€571▲ +2.3%

/ 02 Spot cijene

Cijene uživo i analiza/ 7-day spot · €/g · 24 compounds

Ažurirano svaki satSvi spojevi →

BPC-157 acetate · In Vivo

BPC · CAS 137525-51-0 · MW 1419.5

GHK-cu acetate · In Vivo

GHK · CAS 89030-95-5 · MW 401.91

Mots-c acetate · In Vivo

MOT · CAS 1627580-64-6 · MW 2174.6

CJC 1295 NO DAC acetate · In Vivo

CJC · CAS 863288-34-0 · MW 3367.9

Spoj · kemija

7-dnevni trend

€/g · spot

1d · 7d · 30d

HPLC čistoća

BPCBPC-157 acetate· raw powder

In Vivoacetate

CAS137525-51-0MW1419.5 g/molSolacetateCID9941957SEQGEPPPGKPADDAGLVInChIHEEWEZGQMLZMFE-RKGINYAYSA-N

€156/g

1d~+2.6%7d▼ ~-5.5%30d~+11.1%

≥98%

→

GHKGHK-cu acetate· raw powder

In Vivoacetate

CAS89030-95-5MW401.91 g/molSolacetateCID139035031SEQGly-His-Lys (Cu²⁺)InChILREZPQNYQZAPJC-ACMTZBLWSA-L

€4/g

1d~-0.7%7d▼ ~-3.5%30d~-11.2%

≥98%

→

MOTMots-c acetate· raw powder

In Vivoacetate

CAS1627580-64-6MW2174.6 g/molSolacetateCID146675088SEQMRWQEMGYIFYPRKLRInChIWYTHCOXVWRKRAH-LOKRTKBUSA-N

€277/g

1d~-1.3%7d▼ ~-4.8%30d~-2.8%

≥98%

→

CJCCJC 1295 NO DAC acetate· raw powder

In Vivoacetate

CAS863288-34-0MW3367.9 g/molSolacetateCID56841945SEQY-(D-A)-D-A-I-F-T-Q-S-Y-R-K-V-L-A-Q-L-S-A-R-K-L-L-Q-D-I-L-S-R-NH2InChIXOZMWINMZMMOBR-HRDSVTNWSA-N

€512/g

1d~+1.6%7d▼ ~-1.4%30d~+14.2%

≥98%

→

EPIEpithalon acetate· raw powder

Industrialacetate

CAS64082-79-7MW390.35 g/molSolacetateCID219042SEQAEDGInChIHGHOBRRUMWJWCU-FXQIFTODSA-N

€105/g

1d~+0.5%7d▲ ~+9.3%30d~+3.2%

>90%

→

THYThymosin alpha 1 acetate· raw powder

In Vivoacetate

CAS62304-98-7MW3108.3 g/molSolacetateCID16130571SEQSDAAVDTSSEITTKDLKEKKEVVEEAENInChINZVYCXVTEHPMHE-ZSUJOUNUSA-N

€562/g

1d~-2.2%7d▼ ~-5.7%30d~-4.6%

≥98%

→

THY3Thymulin acetate· raw powder

Industrialacetate

CAS63958-90-7MW858.9 g/molSolacetateCID71300623SEQXAKSQGGSNInChILIFNDDBLJFPEAN-YTAPOSPOSA-N

€165/g

1d~-0.2%7d▼ ~-4.5%30d~-6.0%

>90%

→

AMI5-Amino 1MQ chloride· raw powder

In Vivochloride

CAS685079-15-6MW159.21 g/molSolchlorideCID950107InChIZMJBCEIHNOWCMC-UHFFFAOYSA-O

€2/g

1d~+3.3%7d▼ ~-2.4%30d~-9.1%

≥98%

→

AODAOD-9604 acetate· raw powder

In Vivoacetate

CAS221231-10-3MW1815.1 g/molSolacetateCID71300630SEQYLRIVQCRSVEGSCGFInChIGVIYUKXRXPXMQM-BPXGDYAESA-N

€874/g

1d~-1.6%7d▼ ~-5.4%30d~-9.8%

≥98%

→

DSIDSIP acetate· raw powder

In Vivoacetate

CAS62568-57-4MW848.8 g/molSolacetateCID68816SEQWAGGDASGEInChIZRZROXNBKJAOKB-GFVHOAGBSA-N

€196/g

1d~+3.7%7d▲ ~+7.9%30d~+10.4%

≥98%

→

IPAIpamorelin acetate· raw powder

In Vivoacetate

CAS170851-70-4MW711.9 g/molSolacetateCID9831659SEQXHXFKInChINEHWBYHLYZGBNO-BVEPWEIPSA-N

€243/g

1d~-0.9%7d▼ ~-4.8%30d~+5.3%

≥98%

→

KPV

KPVKPV acetate· raw powder

In Vivo

€223/g

1d~+0.1%7d▼ ~-1.7%30d~-7.5%

≥98%

→

KISKisspeptin-10 acetate· raw powder

In Vivoacetate

CAS374675-21-5MW1302.4 g/molSolacetateCID25240297SEQYNWNSFGLRFInChIRITKWYDZSSQNJI-INXYWQKQSA-N

€285/g

1d~-3.1%7d▼ ~-5.3%30d~-4.3%

≥98%

→

LLALL-37 acetate· raw powder

In Vivoacetate

CAS154947-66-7MW4493 g/molSolacetateCID16198951SEQLLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESInChIPOIUWJQBRNEFGX-XAMSXPGMSA-N

€774/g

1d~+2.8%7d▲ ~+3.7%30d~+0.3%

≥98%

→

MELMelanotan 2 acetate· raw powder

Industrialacetate

CAS121062-08-6MW1024.18 g/molSolacetateCID92432SEQXDHFRWKInChIJDKLPDJLXHXHNV-MFVUMRCOSA-N

€162/g

1d~-3.7%7d▲ ~+5.7%30d~+12.6%

CAS53-84-9MW663.4 g/molCID5892InChIBAWFJGJZGIEFAR-NNYOXOHSSA-N

€1/g

1d~+4.7%7d▲ ~+8.5%30d~+8.5%

≥98%

→

PEG

PEGPEG-MGF acetate· raw powder

In Vivoacetate

MW4888 g/molSolacetateSEQYQPPSTNKNTKSQRRKGSTFEERK-NH2

€1,380/g

1d~+1.4%7d▲ ~+11.0%30d~+14.9%

≥98%

→

PTAPT-141 acetate· raw powder

In Vivoacetate

CAS189691-06-3MW1025.2 g/molSolacetateCID9941379SEQXDHFRWKInChIFFHBJDQSGDNCIV-MFVUMRCOSA-N

€378/g

1d~0.0%7d▲ ~+6.3%30d~+0.4%

≥98%

→

RETRetatrutide acetate· raw powder

In Vivoacetate

CAS2381089-83-2MW4731.33 g/molSolacetateCID171390338SEQY-Aib-QGTFTSDYSI-αMeLeu-LDK-Lys(19-carboxy-nonadecanoyl-γGlu-AEEA)-AQ-Aib-AFIEYLLEGGPSSGAPPPS-NH₂InChIMLOLQJNKXBNWFW-SAGGEDDASA-N

€164/g

1d~-3.6%7d▼ ~-8.2%30d~-12.4%

≥98%

→

SS3SS-31 acetate· raw powder

In Vivoacetate

CAS736992-21-5MW639.8 g/molSolacetateCID11764719SEQRXKFInChISFVLTCAESLKEHH-WKAQUBQDSA-N

€329/g

1d~+2.6%7d▲ ~+11.0%30d~+2.0%

≥98%

→

SELSelank acetate· raw powder

In Vivoacetate

CAS129954-34-3MW751.9 g/molSolacetateCID11765600SEQTKPRPGPInChIJTDTXGMXNXBGBZ-YVHUGQOKSA-N

€187/g

1d~+1.7%7d▼ ~-0.9%30d~-9.1%

≥98%

→

SEMSemax acetate· raw powder

In Vivoacetate

CAS80714-61-0MW813.9 g/molSolacetateCID9811102SEQMEHFPGPInChIAFEHBIGDWIGTEH-AQRCPPRCSA-N

€192/g

1d~+1.4%7d▲ ~+2.9%30d~+9.5%

≥98%

→

TESTesamorelin acetate· raw powder

In Vivoacetate

CAS218949-48-5MW5136 g/molSolacetateCID16137828SEQYADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARLInChIQBEPNUQJQWDYKU-BMGKTWPMSA-N

€541/g

1d~+1.4%7d▲ ~+5.8%30d~+3.0%

≥98%

→

THY4Thymosin beta-4 acetate· raw powder

In Vivoacetate

CAS77591-33-4MW4963 g/molSolacetateCID45382195SEQSDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGESInChIUGPMCIBIHRSCBV-UHFFFAOYSA-N

€571/g

1d~+0.6%7d▲ ~+2.3%30d~-2.1%

≥98%

→

Prices derive from ViraChem’s active network of trade, converted to EUR at the ECB daily reference rate for each transaction date. Metodologija →

24 compounds·€/g·ECB · EUR/USD 1.1188·Updated 07:59 CET·Q4 2026

/ 03 Puls novosti

Puls vijesti i najnovija istraživanja/ otvoreni registri · blog

Ažurirano svaki satCijeli feed →

Feed R&D novostiEUROPE PMC · CT.GOV

13 OCT

PreprintbioRxiv· immunology

Self-reactive human CD8⁺ T cells restricted by HLA-E mediate immunoregulatory and antiviral functions

HLA-E constitutively presents self VL9 peptides on healthy cells, signaling an intact HLA class I pathway and protecting cells from natural killer cell attack. Beyond this canonical role, HLA-E-restricted CD8 T cells …

Walters, L. C.; Guo, X.; Casquero, C.; Urbach, J. M.; Leddy, O.; Cakan, E.; Chan, A. O.; Balivada, P. A.; Wisner, H.; Bryson, B. D.; Whit…

↗

13 OCT

Klinička studijaClinicalTrials.gov· PHASE3 · RECRUITING

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

The main goals of this study are to learn about the safety of sacituzumab tirumotecan with bevacizumab and if people tolerate it; and if people who take sacituzumab tirumotecan with or without bevacizumab live longer …

Merck Sharp & Dohme LLC

↗

13 OCT

Klinička studijaClinicalTrials.gov· PHASE2 · NOT_YET_RECRUITING

Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer

This trial proposes to evaluate the immunologic and potential clinical effectiveness of intensive locoregional sequential intraperitoneal (IP) cisplatin (IPC) with intravenous (iv) paclitaxel followed by peritoneal in…

Kalinski, Pawel, MD, PhD

↗

13 OCT

Klinička studijaClinicalTrials.gov· PHASE2 · RECRUITING

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates the use of a screening tool and specific laboratory tests to help improve participants' ability to register to clinical trials throughout the…

National Cancer Institute (NCI)

↗

13 OCT

Klinička studijaClinicalTrials.gov· PHASE2 · RECRUITING

Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors

Patients with with recurrent or progressive medulloblastoma, ependymoma, atypical teratoid rhabdoid tumor (ATRT), and CNS tumors of various histologies have a very poor prognosis whether treated with conventional chem…

Medical University of Vienna

↗

13 OCT

Klinička studijaClinicalTrials.gov· PHASE2 · NOT_YET_RECRUITING

A Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage Non-Small Cell Lung Cancer (ROSETTA Lung-220)

The purpose of this study is to assess the safety, tolerability, and surgical feasibility of preoperative Pumitamig-based therapy and other molecules in resectable, Early-Stage Non-Small Cell Lung Cancer

Bristol-Myers Squibb

↗

Sve vijesti →

Najnovija istraživanjaBILJEŠKE S TERENA · ANALIZA

Analytical Science

Novo Nordisk Study Finds Follow-On Liraglutide Less Physically Stable Than Originator

ViraChem Research Desk05 Aug6 min čitanja

Clinical Research

Genetic Analysis Argues for Lower GIP While Tirzepatide Agonises the Receptor

ViraChem Research Desk05 Aug8 min čitanja

Regulatory

Consensus Statements Fill the GLP-1 Evidence Gap Regulators Have Not

ViraChem Research Desk02 Aug8 min čitanja

Clinical Research

Low-Dose Tirzepatide Matched 5 mg on Weight Loss in a 112-Patient Japanese Cohort

ViraChem Research Desk02 Aug8 min čitanja

Clinical Research

Semaglutide Withdrawal Trial Asks Whether Tapering Beats Stopping Cold

ViraChem Research Desk31 Jul8 min čitanja

Svi članci →

24 compounds·€/g·ECB · EUR/USD 1.1188·Updated 07:59 CET·Q4 2026

/ 04 Metodologija

Kako nastaju podaci/ izvor · pretvorba · osvježavanje

Cijela metodologija →

M · 01

Podaci iz stvarne trgovine

Svaka promptna cijena proizlazi iz stvarnih narudžbi koje prolaze kroz trgovinsku mrežu ViraChema u EU — ne iz anketa niti iz prikupljanja cjenika.

Izvor →M · 02

EUR preračunat po ECB-u

Transakcije izvan eura preračunavaju se u eure po dnevnom referentnom tečaju ESB-a za odgovarajući datum trgovine. Ista konvencija za sve promptne cijene.

Konverzija →M · 03